North Tower
6th Floor 333 Ludlow Street
Stamford, CT 06902
United States
888 729 1206
https://www.genedx.com
Sector(es): Healthcare
Sector: Health Information Services
Empleados a tiempo completo: 1000
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Ms. Katherine A. Stueland | President, CEO & Director | 745,91k | N/A | 1976 |
Mr. Kevin Feeley | Chief Financial Officer | 488,19k | N/A | 1981 |
Ms. Karen Ponchner | Senior VP & Head of Operations | N/A | N/A | N/A |
Mr. Eric Olivares Ph.D. | Chief Product & Technology Officer | N/A | N/A | N/A |
Mr. Devin K. Schaffer J.D., M.B.A. | General Counsel | N/A | N/A | N/A |
Mr. Paul Kruszka M.D. | Chief Medical Officer | N/A | N/A | N/A |
Ms. Melanie Duquette | Chief Growth Officer | N/A | N/A | N/A |
Sabrina Dunbar | Chief of Staff | N/A | N/A | N/A |
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
El ISS Governance QualityScore de GeneDx Holdings Corp., a día 1 de mayo de 2024, es 10. Las puntuaciones base son Auditoría: 10; Tablero: 9; Derechos de los accionistas: 8; Compensación: 10.